Novel Association between Plasma Matrix Metalloproteinase-9 and Risk of Incident Atrial Fibrillation in a Case-Cohort Study: The Atherosclerosis Risk in Communities Study

QR Code

Novel Association between Plasma Matrix Metalloproteinase-9 and Risk of Incident Atrial Fibrillation in a Case-Cohort Study: The Atherosclerosis Risk in Communities Study

Background: Previous cross-sectional studies have suggested that biomarkers of extracellular matrix remodelling are associated with atrial fibrillation (AF), but no prospective data have yet been published. Hence, we examine whether plasma matrix metalloproteinases (MMP) and their inhibitors are rel...

Full description

Bibliographic Details
Main Authors:	Huxley, Rachel, Lopez, F., MacLehose, R., Eckfeldt, J., Couper, D., Leiendecker-Foster, C., Hoogeveen, R., Chen, L., Soliman, E., Agarwal, S., Alonso, A.
Format:	Journal Article
Published:	2013
Online Access:	http://hdl.handle.net/20.500.11937/35490

Similar Items

Blood lipid levels, lipid-lowering medications, and the incidence of atrial fibrillation: The atherosclerosis risk in communities study
by: Lopez, F., et al.
Published: (2012)

High-Sensitivity Cardiac Troponin T and the Risk of Incident Atrial Fibrillation: The Atherosclerosis Risk in Communities (ARIC) Study
by: Filion, K., et al.
Published: (2011)

Absolute and attributable risks of atrial fibrillation in relation to optimal and borderline risk factors: The atherosclerosis risk in communities (ARIC) study
by: Huxley, Rachel, et al.
Published: (2011)

High-sensitivity cardiac troponin T and the risk of incident atrial fibrillation: the Atherosclerosis Risk in Communities (ARIC) study
by: Filion, K., et al.
Published: (2015)

Type 2 diabetes, glucose homeostasis and incident atrial fibrillation: The Atherosclerosis risk in communities study
by: Huxley, Rachel, et al.
Published: (2012)

Physical activity, obesity, weight change, and risk of atrial fibrillation the atherosclerosis risk in communities study
by: Huxley, Rachel, et al.
Published: (2014)

Relation of serum phosphorus levels to the incidence of atrial fibrillation (from the Atherosclerosis Risk in Communities [ARIC] study)
by: Lopez, F., et al.
Published: (2013)

Serum and dietary magnesium and incidence of atrial fibrillation in whites and in African Americans: Atherosclerosis risk in communities (ARIC) study
by: Misialek, J., et al.
Published: (2013)

Birth weight and the risk of atrial fibrillation in whites and African Americans: The atherosclerosis risk in communities (ARIC) study
by: Lawani, S., et al.
Published: (2014)

Atrial fibrillation and cognitive decline-the role of subclinical cerebral infarcts: The atherosclerosis risk in communities study
by: Chen, L., et al.
Published: (2014)

Carotid Intima-Media Thickness and Carotid Distensibility are Associated with Incident Atrial Fibrillation: The Atherosclerosis Risk in Communities (ARIC) Study
by: Chen, L., et al.
Published: (2012)

Atrial Fibrillation is Associated with Higher Risk of Dementia and Post-Dementia Hospitalization Mortality in Individuals Without Stroke: The Atherosclerosis Risk in Communities (ARIC) Study
by: Chen, L., et al.
Published: (2011)

Blood lipids and the incidence of atrial fibrillation: The multi-ethnic study of atherosclerosis and the framingham heart study
by: Alonso, A., et al.
Published: (2014)

Impact of gout on the risk of atrial fibrillation
by: Kuo, Chang-Fu, et al.
Published: (2016)

Meta-analysis of cohort and case-control studies of type 2 diabetes mellitus and risk of atrial fibrillation
by: Huxley, Rachel, et al.
Published: (2011)

Obesity related risk of sudden cardiac death in the atherosclerosis risk in communities study
by: Adabag, S., et al.
Published: (2015)

Screening for atrial fibrillation in primary care
by: Taggar, Jaspal
Published: (2017)

Bleeding-related admissions in patients with atrial fibrillation receiving antithrombotic therapy: results from the Tasmanian Atrial Fibrillation
by: Admassie, E., et al.
Published: (2017)

Thromboembolism and Mortality in the Tasmanian Atrial Fibrillation Study
by: Admassie, E., et al.
Published: (2018)

Abdominal Obesity is an Independent Risk Factor for Sudden Cardiac Death in Non-Smoking Individuals: The Atherosclerosis Risk in Communities Study
by: Adabag, S., et al.
Published: (2013)

ENVIRONMENTAL SUSTAINABILITY APPRAISAL OF THE ATRIAL FIBRILLATION CARE PATHWAY
by: Munawar, Sana
Published: (2016)

Adherence to Oral Anticoagulants in Atrial Fibrillation: An Australian Survey
by: Obamiro, K., et al.
Published: (2018)

Anticoagulation knowledge in patients with atrial fibrillation: An Australian survey
by: Obamiro, K., et al.
Published: (2018)

Screening for atrial fibrillation in primary care: from recommendation to implementation
by: Taggar, Jaspal, et al.
Published: (2016)

Stroke prevention in atrial fibrillation: An update on current management strategies
by: Hall, Toby, et al.
Published: (2013)

The burden and implications of preoperative atrial fibrillation in Australian heart valve surgery patients
by: Russell, E., et al.
Published: (2017)

Knowledge of atrial fibrillation and stroke prevention: development of questionnaire and validation of results
by: Mohamed, Sahimi, et al.
Published: (2017)

Changes in Oral Anticoagulant Prescribing for Stroke Prevention in Patients With Atrial Fibrillation
by: Admassie, E., et al.
Published: (2017)

Anticoagulant use in patients with nonvalvular atrial fibrillation: has prescribing improved?
by: Bista, D., et al.
Published: (2016)

Patient Characteristics and Antithrombotic Prescribing Patterns in Patients with Atrial Fibrillation in Tasmania
by: Bista, D., et al.
Published: (2017)

Knowledge of Atrial Fibrillation and Stroke Prevention: Development of Questionnaire and Validation of Results
by: Sahimi, Mohamed, et al.
Published: (2016)

Safety and efficacy of dabigatran versus warfarin in Asian patients with atrial fibrillation
by: Inche Mat, Liyana Najwa, et al.
Published: (2020)

Troponin T, NT-proBNP, and Incidence of Stroke: The Atherosclerosis Risk in Communities (ARIC) Study
by: Folsom, A., et al.
Published: (2013)

Association between use of non–vitamin k oral anticoagulants with and without concurrent medications and risk of major bleeding in nonvalvular atrial fibrillation
by: Chang, Shang-Hung, et al.
Published: (2017)

Gastrointestinal bleeding risk assessment using HAS-Bled in atrial fibrillation patients who are receiving warfarin in Hospital Universiti Sains Malaysia
by: Idris, Sri Salwani
Published: (2018)

Gastrointestinal bleeding risk assessment using HAS-Bled in atrial fibrillation patients who are receiving warfarin in Hospital Universiti Sains Malaysia
by: Idris, Sri Salwani Idris
Published: (2018)

A Summary of the Literature Evaluating Adherence and Persistence with Oral Anticoagulants in Atrial Fibrillation
by: Obamiro, K., et al.
Published: (2016)

The Tasmanian atrial fibrillation study: Transition to direct oral anticoagulants 2011-2015
by: Alamneh, E., et al.
Published: (2017)

Early experiences with edoxaban for stroke prevention in atrial fibrillation in the Southeast Asia region
by: Bimbo Diaz, Alejandro, et al.
Published: (2023)

A comparative analysis of risk factors for stroke in blacks and whites: The Atherosclerosis Risk in Communities study
by: Huxley, Rachel, et al.
Published: (2014)

Cannot write session to /tmp/vufind_sessions/sess_ievqktg93jc1ihn4oo12b78j25